ConductScience.org, home

Paper37889752

KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.

Zavitsanou AM and 26 others. Cell Rep, 2023. Cited by 150 papers, by iCite.

Cite this record

ConductScience Library. KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Papers, record 37889752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37889752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.
PubMed
Journal
Cell Rep
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
150
iCite
Relative citation ratio, by iCite
11.8
iCite
Revised in PubMed
2024-02-21
PubMed

Authors27

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zavitsanou AMAnastasia-Maria
2Pillai RRay
3Hao YYuan
4Wu WLWarren L
5Bartnicki EEric
6Karakousi TTriantafyllia
7Rajalingam SSahith
8Herrera AAlberto
9Karatza AAngeliki
10Rashidfarrokhi AAli
11Solis SSabrina
12Ciampricotti MMetamia
13Yeaton AHAnna H
14Ivanova EEllie
15Wohlhieter CACorrin A
16Buus TBTerkild B
17Hayashi MMakiko
18Karadal-Ferrena BBurcu
19Pass HIHarvey I
20Poirier JTJohn T

Source PubMed

See all 27 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenocarcinoma of LungMajor topic
Lung NeoplasmsMajor topic
Humans
Kelch-Like ECH-Associated Protein 1
NF-E2-Related Factor 2
Immune Evasion
Cell Line, Tumor
Mutation
Immunotherapy
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA271245NCI NIH HHSUnited StatesR01CA271245PubMed and NIHNIH RePORTER
T32 CA009161NCI NIH HHSUnited StatesT32CA009161PubMed and NIHNIH RePORTER
P01 CA229086NCI NIH HHSUnited StatesP01CA229086PubMed and NIHNIH RePORTER
P30 CA016087NCI NIH HHSUnited StatesP30CA016087PubMed and NIHNIH RePORTER
R01 AI143861NIAID NIH HHSUnited StatesR01AI143861PubMed and NIHNIH RePORTER
R01 CA252239NCI NIH HHSUnited StatesR01CA252239PubMed and NIHNIH RePORTER
R01 HL125816NHLBI NIH HHSUnited StatesR01HL125816PubMed and NIHNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMedNIH RePORTER
T32 AI100853NIAID NIH HHSUnited StatesT32AI100853PubMed and NIHNIH RePORTER
R37 CA222504NCI NIH HHSUnited StatesR37CA222504PubMed and NIHNIH RePORTER
F30 CA247020NCI NIH HHSUnited StatesF30CA247020PubMed and NIHNIH RePORTER
T32 GM007308NIGMS NIH HHSUnited StatesT32GM007308PubMed and NIHNIH RePORTER
R01 CA227649NCI NIH HHSUnited StatesR01CA227649PubMed and NIHNIH RePORTER

Download CSV of grants

References112

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132719479Inducible de novo expression of neoantigens in tumor cells and mice.Nat Biotechnol2021https://conductscience.org/library/papers/32719479PubMed
222331464PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function.Mol Cell Biol2012https://conductscience.org/library/papers/22331464PubMed
326586766Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development.Cancer Discov2016https://conductscience.org/library/papers/26586766PubMed
430108253Keap1-MCM3 interaction is a potential coordinator of molecular machineries of antioxidant response and genomic DNA replication in metazoa.Sci Rep2018https://conductscience.org/library/papers/30108253PubMed
528187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
628967864Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer.Elife2017https://conductscience.org/library/papers/28967864PubMed
728486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
825337879Rapid modelling of cooperating genetic events in cancer through somatic genome editing.Nature2014https://conductscience.org/library/papers/25337879PubMed
930371878COSMIC: the Catalogue Of Somatic Mutations In Cancer.Nucleic Acids Res2019https://conductscience.org/library/papers/30371878PubMed
1028967920Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.Nat Med2017https://conductscience.org/library/papers/28967920PubMed
1129025772Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.Cancer Discov2017https://conductscience.org/library/papers/29025772PubMed
1225818339Immune evasion in cancer: Mechanistic basis and therapeutic strategies.Semin Cancer Biol2015https://conductscience.org/library/papers/25818339PubMed
1328650338IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.J Clin Invest2017https://conductscience.org/library/papers/28650338PubMed
1426833127STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.Cancer Res2016https://conductscience.org/library/papers/26833127PubMed
1528986418CD169+ macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen.Sci Immunol2017https://conductscience.org/library/papers/28986418PubMed
1628178570Serine Is an Essential Metabolite for Effector T Cell Expansion.Cell Metab2017https://conductscience.org/library/papers/28178570PubMed
1732786189The Effect of Advances in Lung-Cancer Treatment on Population Mortality.N Engl J Med2020https://conductscience.org/library/papers/32786189PubMed
1821930769Type I interferon is selectively required by dendritic cells for immune rejection of tumors.J Exp Med2011https://conductscience.org/library/papers/21930769PubMed
1934597124A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response.Sci Immunol2021https://conductscience.org/library/papers/34597124PubMed
2015282312Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.Mol Cell Biol2004https://conductscience.org/library/papers/15282312PubMed

See all 112 referencesDownload CSV of references

Cited by116

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.

PMIDTitleJournalYearIn PapersSource
42901717PCSK9 drives acquired resistance to anti-PD-1 immunotherapy through cystine metabolic reprogramming in lung cancer.J Immunother Cancer2026https://conductscience.org/library/papers/42901717PubMed
42826199Tumor cell-intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer.Sci Adv2026https://conductscience.org/library/papers/42826199PubMed
42708106The KEAP1-NFE2L2/NRF2 Axis in Non-Small Cell Lung Cancer Radioresistance: Redox Homeostasis and Emerging DNA Damage Response Mechanisms.Cancer Manag Res2026https://conductscience.org/library/papers/42708106PubMed
42707968Adenosine signaling in tumor immune escape: metabolic checkpoints, myeloid suppression, and combination immunotherapy.Front Oncol2026https://conductscience.org/library/papers/42707968PubMed
42676634Immunotherapy plus chemotherapy improves survival in SMARCA4-deficient NSCLC: a real-world cohort study.Front Immunol2026https://conductscience.org/library/papers/42676634PubMed
42621827Gut microbiota-derived metabolites as context-dependent modulators of Nrf2 signaling in inflammation-driven carcinogenesis.Gut Microbes2026https://conductscience.org/library/papers/42621827PubMed
42587156Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.Nature2026https://conductscience.org/library/papers/42587156PubMed
42558804A Glutathione Metabolism-Related Transcriptomic Signature for Prognostic Assessment and Biological Characterization of Lung Adenocarcinoma.Cancer Inform2026https://conductscience.org/library/papers/42558804PubMed
42519324Single-cell and spatial omics in non-small cell lung cancer: dissecting metabolic reprogramming and tumor-immune ecosystems for precision pharmacology.Front Immunol2026https://conductscience.org/library/papers/42519324PubMed
42512269Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor.Cancers (Basel)2026https://conductscience.org/library/papers/42512269PubMed
42491177From metabolism to genome integrity: NRF2 as a key mediator of cancer therapy response.Front Cell Dev Biol2026https://conductscience.org/library/papers/42491177PubMed
42476096SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.Transl Oncol2026https://conductscience.org/library/papers/42476096PubMed
42447505Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.Cancer Res Commun2026https://conductscience.org/library/papers/42447505PubMed
42440255Pharmacogenomics in oncology: mutation-targeted therapy and biomarker integration in non-small cell lung cancer.Clin Transl Oncol2026https://conductscience.org/library/papers/42440255PubMed
42435178Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435178PubMed
42426902Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications.J Hematol Oncol2026https://conductscience.org/library/papers/42426902PubMed
42317338Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42317338PubMed
42297823Tumor suppressor genotype influences the extent and mode of immunosurveillance in lung cancer.Nat Commun2026https://conductscience.org/library/papers/42297823PubMed
42255480Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibition.Front Cell Dev Biol2026https://conductscience.org/library/papers/42255480PubMed
42187558STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.Curr Oncol2026https://conductscience.org/library/papers/42187558PubMed

See all 116 cited byDownload CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BATF355509PubTator's text mininghttps://conductscience.org/library/genes/55509NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CLEC9A283420PubTator's text mininghttps://conductscience.org/library/genes/283420NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL94283PubTator's text mininghttps://conductscience.org/library/genes/4283NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
GLS2744PubTator's text mininghttps://conductscience.org/library/genes/2744NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNAR13454PubTator's text mininghttps://conductscience.org/library/genes/3454NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
ITGAE3682PubTator's text mininghttps://conductscience.org/library/genes/3682NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
ITGAX3687PubTator's text mininghttps://conductscience.org/library/genes/3687NCBI Gene
KEAP19817PubTator's text mininghttps://conductscience.org/library/genes/9817NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37889752

GET https://conductscience.org/api/papers/v1/37889752/authors?page=2